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Purpose: The purpose of this study was to investigate the high potential of glucose in inhibiting the innate immune in
cultured human cornea epithelial cells (HCEC) and try to determine whether the role of high glucose on the HCEC relate
to toll-like receptor (TLR)2 and TLR4.
Methods: Cells were cultured for 3 days in 5 mmol/l (normal glucose). Then high glucose (25 mmol/l) was added along
with normal glucose with daily changes in media for 24 h. The cells were also treated with mannitol as an osmotic control.
The cellular abundance of the mRNAs for TLR2 and TLR4 was determined by real-time polymerase chain reaction analysis.
The proteins of TLR2 and TLR4 were also compared by immunofluorescent staining and western blot. The release of
interleukin 6 (IL-6) and IL-8 from cultured HCEC was measured using enzyme-linked immunosorbent assays (ELISA)
in the presence and absence of specific blocking antibodies to TLR2 and TLR4.
Results: Incubation of HCEC with high glucose showed that the mRNA expression of TLR2 and TLR4 was markedly
inhibited. Immunofluorescent staining and western blot analysis confirmed that the protein expression of TLR2 and TLR4
was downregulated in response to high glucose. The result of ELISA also showed that the release of IL-6 and IL-8 can
be inhibited by high glucose, but these inhibitions were partly counteracted after pretreatment with anti-TLR2 and/or anti-
TLR4 monoclonal antibody. The results also showed that the osmotic control did not affect the expression of TLR2, TLR4,
and IL-6, 8.
Conclusions: High glucose may decrease the innate immune through TLRs in cornea epithelium.
With  rapid  increases  in  the  prevalence  of  diabetes
mellitus (DM) worldwide, ocular complications have become
a leading cause of blindness in the world [1]. In addition to
abnormalities of the retina (diabetic retinopathy) and the lens
(cataract), various types of corneal epithelial disorders are also
relatively common in persons with DM [2]. Abnormalities of
the cornea include defects in epithelium-basement membrane
adhesion and altered epithelial functions such as basal cell
degeneration [3], superficial punctate keratitis [4], breakdown
of barrier function [5], fragility [6], recurrent erosions, and
persistent epithelial defects [7]. Epithelial defect may also
result  in  sight-threatening  complications,  such  as  stromal
opacification, surface irregularity, and microbial keratitis [8].
The  cornea  epithelial  cells  constitute  the  first  line  of
defense against microbial pathogens, possess the ability to
detect their presence [9-11], and play an important role in
inflammatory responses by releasing various mediators, such
as  cytokines  and  chemokines  [12,13].  Recently,  Toll-like
receptors (TLRs) have proven essentialin triggering the innate
immune  response  by  recognizing  pathogen-associated
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molecular patterns (PAMP) and stimulating the activity of
host immune cells against several microbial products [14].
TLRs  are  activated  by  both  endogenous  and  exogenous
agonists of microbial and nonmicrobial origin. TLR activation
by  their  agonists  triggers  a  signaling  cascade,  leading  to
cytokine production and initiation of an adaptive immune
response [15]. TLR2 and TLR4 bind to components of the
Gram-positive and -negative bacteria, respectively [15]. They
are  expressed  in  multiple  cells  and  tissues,  including  in
corneas. The interactionsbetween inflammation and diabetes
have clear implications for the immune system. Mohammad
et al. [16] reported increased TLR2 and TLR4 expression in
type 1 diabetic non-obese diabetic (NOD) mice, correlating
with increased nuclear factor -kappa-B (NF-κB) activation in
response  to  endotoxin,  and  increased  proinflammatory
cytokines. Using TLR2−/−, TLR4−/−knockouts, and NOD
mice, Kim et al. [17] demonstrated that TLR2 senses β-cell
death  and  contributes  to  the  instigation  of  autoimmune
diabetes. Devaraj et al. [18] showed increased TLR2 and
TLR4 expression, intracellular signaling, and TLR-mediated
inflammation in monocytes with significant correlation to
HbA1c (A1C) levels in type 1 diabetic patients. Also, Creely
et al. [19] showed increased TLR2 expression in the adipose
tissue of type 2 diabetic patients with strong correlates to
endotoxin levels. Taken together, these observations suggest
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3384a  potential  role  for  TLR2  and  TLR4  in  the  pathology  of
diabetes.
However, data examining the mechanism of TLR2 and
TLR4  expression  and  function  of  cornea  in  diabetes  are
unknown. Therefore, this study aimed to test the ability of high
glucose, one of the key abnormalities of the diabetic condition,
to induce TLRs expression in human corneal epithelium.
METHODS
Reagents  and  antibodies:  Dulbecco's  Modified  Eagle
Medium (DMEM), F12, fetal bovine serum (FBS), glucose,
and  phosphate-buffered  saline  (PBS)  were  obtained  from
Invitrogen-Gibco (New York, NY). All media and cytokines
used for cell culture were endotoxin minimized. Tissue culture
dishes and six-well chamber slides were from BD (New York,
NY). Affinity purified, monoclonal, antihuman TLR2 and
TLR4 and normal mouse immunoglobulin G (IgG) were from
eBioscience (San Diego, CA). The second antibody was cy3
from Beyotime Biotechnology (Beyotime, China).
2-(4-Amidinophenyl)-6-indolecarbamidine
dihydrochloride (DAPI dihydrochloride) was used to dye the
nuclear  (Beyotime  Biotechnology).  Paired  antibodies  for
human IL-6 and IL-8 enzyme-linked immunosorbent assays
(EIA) were from BD. RNeasy Mini kit was from Qiagen
(Valencia, CA) was used for RNA extraction. RNA PCR kits
were from Promega (Fitchburg, WI), Ethidium bromide, DNA
molecular size markers and agarose were from Gene Tech
(Shanghai, China). SYBR Green PCR Kit was from Applied
Biosystems (Foster City, CA).
Culture  of  immortalized  human  corneal  epithelial  cells:
Simian virus (SV) 40 immortalized human corneal epithelial
cells (HCEC) were cultured at 37 °C under 95% humidity and
5% CO2 in DMEM/F12 containing10% FBS, 5 μg/ml insulin,
0.1 μg/ml cholera toxin, 5 ng/ml human epidermal growth
factor, and 40 μg/ml gentamicin supplemented with 5 mmol/
l (normal glucose), 25 mmol/l D-glucose (high glucose), or 5
mmol/l D-glucose plus 20 mmol/l mannitol (high mannitol).
The cells were kindly provided by Dr Zan Pan (New York
University, New York, NY). At last the supernatants were
collected and stored at −80 °C after centrifugation to evaluate
the releases of IL-6 and IL-8 and the cells were used to extract
the mRNA and protein to evaluate the expression of the TLRs.
Reversed transcript PCR (RT–PCR): Total RNA prepared
from confluent monolayers of HCEC was used to evaluate the
expression of TLR mRNA. Qiagen RNeasy Mini kit was used
for RNA extraction. Total RNA samples were then reverse
transcribed in a ﬁnal volume of 20 μl containing 1 µg RNA,
50  mM  Tris-HCl,  75  mM  KCl,  3  mM  MgCl2,  5  mM
dithiothreitol, 20 U of RNase Inhibitor, 1µl (1μg) random
primer, 0.5mM each dNTP and 200 U RNase H-free reverse
transcriptase (Promega). The following primer pair was used
for  the  analysis  of  glyceraldehyde-3-phosphate
dehydrogenase  (GAPDH)  by  RT–PCR:  Upstream  5′-CGG
AGT CAA CGG ATT TGG TCG TAT-3′ and Downstream
5′-AGC CTT CTC CAT GGT TGG TGA AGA C-3′.The
annealing temperature of the primers was 60 °C. Each PCR
was performed in a 20 µl solution containing 1 µl RT reaction
products, 10× PCR buffer (2 µl), 1.8 mM MgCl2, 0.1 mM each
dNTP, 0.1 µM of upstream primer, 0.1 µM of downstream
primer, and 0.5 U Taq DNA polymerase. A negative control
(the PCR without a preceding RT step) for each sample was
run to assess whether there was residual genomic DNA in the
DNase-treated samples.
Real-time PCR: Real-time PCR was performed in an ABI
PRISM 7500 Sequence Detection System Thermal Cycler
(Applied Biosystems). Real-time PCR was performed on a
volume of 15 μl containing 1.5 μl (50 ng) of cDNA and
13.5 μl of master mix containing 7.5 μl of mix (SYBR Green
PCR Master Mix; Applied Biosystems), 0.75 μl of each primer
(10 pmol/l), and 4.5 μl of diethyl pyrocarbonate–treated water.
The primers are listed in Table 1. The program was set at 50 °C
for 2 min and 95 °C for 10 min, followed by 40 cycles of
denaturation at 95 °C for 15 s, annealing at 60 °C for 60 s. The
melting curve was analyzed by elevating the temperature from
60 °C to 95 °C while monitoring ﬂuorescence. SYBR green
ﬂuorescence  was  monitored  after  each  elongation  period.
Samples  were  ampliﬁed  with  GAPDH  primers  for
determination of the initial relative quantity of cDNA in each
sample, and then all PCR products were normalized to that
amount. Negative controls (without template) were produced
for each run.
Samples  were  ampliﬁed  in  triplicates;  averages  were
calculated and differences in C (t) data were evaluated by
Sequence Detection Software V1.3.1 (Applied Biosystems).
Data analysis used the comparative Ct method (ΔΔCt method)
with the following formula: ΔCt=Ct (Target, TLR)-Ct (Endo,
GAPDH).  The  comparative  ΔΔCt  calculation  involved
finding the difference between ΔCt of treated cells and the
mean value of the ΔCt from the untreated cells. Fold increase
in the expression of specific mRNA in treated cells compared
to untreated cells was calculated as 2-(ΔΔCt). Data are expressed
as RQ (relative quantity) and differences are shown in the
TABLE 1. PRIMERS FOR REAL-TIME PCR .
Target
gene GenBank Forward sequence(5′–3′) Reverse sequence (5′–3′)
Amplicon size
(bp)
TLR2 NM_003264.3 TCTCCCATTTCCGTCTTTTT GGTCTTGGTGTTCATTATCTTC 125
TLR4 NR_024168.1 GAAGCTGGTGGCTGTGGA TGATGTAGAACCCGCAAG 213
GAPDH NG_007073.2 CCCCACACACATGCACTTACC TTGCCAAGTTGCCTGTCCTT 100
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according to the software results.
Immunofluorescent staining: The HCEC were seeded onto
Lab-Tek tissue culture chamber slides without FBS for 24 h.
Then the cells were washed with Hank's Balance Salt Solution
(Invitrogen-Gibco).  The  slides  were  then  fixed  in  4%
paraformaldehyde for 15 min and wash with 10× tris buffered
saline (TBS) 3 times for 5 min each time. Then fixed cells
were  incubated  in  blocking  buffer  of  5%  BSA  (Proliant,
Ankeny, IA) and 0.1% Triton X-100 in PBS for 30 min at
room  temperature.  Cells  were  then  incubated  with  the
following dilutions of primary antibodies for 1 h at room
temperature: primary mouse anti human TLR2 and TLR4
monoclonal antibodies (20 μg/ml in 5% BSA-PBS) or with
mouse IgG (control). The secondary antibodies, conjugated to
Cy3, were diluted 1:200 in 5% BSA-PBS and incubated for 1
h at room temperature. Coverslips were washed three times in
PBS  for  5  min  each  time,  mounted  (Vectashield;  Vector
Laboratories,  Burlingame,  CA),  and  viewed  with  a
fluorescence microscope (Zeiss microscope Imager Z1; Zeiss,
Oberkochen,  Germany).  DNA-intercalating  dye  DAPI
dihydrochloride  was  used  for  nuclear  labeling.  For  the
negative control, preimmune mouse serum was substituted for
the primary antibody.
Western  blot:  Cells  were  lysed  with
radioimmunoprecipitation  (RIPA)  buffer  (150  mM  NaCl,
100 mM Tris-HCl [pH 7.5], 1% deoxycholate, 0.1% SDS, 1%
Triton X-100, 50 mM NaF, 100 mM sodium pyrophosphate,
3.5 mM sodium orthovanadate, proteinase inhibitor cocktails,
and  0.1  mM  phenylmethylsulfonyl  fluoride  [PMSF]),  and
protein concentration was determined with the bicinchoninic
acid  (BCA)  assay  (Micro  BCA;  Pierce  Biotechnology,
Rockford, IL). Equal amounts of protein were mixed with
SDS–PAGE  protein  loading  buffer  and  boiled  for  5  min.
Proteins were separated by sodium dodecyl sulfate–PAGE in
Tris/glycine/SDS buffer (25 mM Tris, 250 mM glycine and
0.1% SDS) and electro-blotted onto nitrocellulose transfer
membranes.  After  blocking  with  5%  nonfat  milk,  the
membranes  were  incubated  overnight  with  polyclonal
antibodies  againstTLR2  and  TLR4  (1:400  dilution  in  5%
nonfat milk) in TBST. GAPDH was used as control. After they
were washed three times in PBST, membranes were incubated
with secondary HRP-conjugated antimouse IgG for 1 h. After
the membranes were again were washed with PBST 3 times,
5  min  each.  Immune  complexes  were  visualized  with  an
enhanced chemiluminescence reagent (Pierce, Rockford, IL).
Results were quantified by capturing the exposed X-ray film
image  and  using  area  measurements  from  image  analysis
software.
Enzyme-linked  immunosorbent  assay  (ELISA):  The
concentration of IL-6 and IL-8, in the cell culture supernatant
fluids was determined by ELISA. The assay was performed
according to manufacturer’s instructions. Results from two
representative experiments are presented as the means ±SEM
of triplicate cytokine measurements.
Statistical  analysis:  Data  are  expressed  as  mean±SEM  of
triplicates from an experiment that was repeated 3 times with
similar  results.  Statistical  significance  of  differences  was
determined  with  the  non-parametric  Wilcoxon  test  and
Student’s t test using the SPSS version 11.5 (SPSS, Chicago,
IL). Differences were considered statistically significant at
p<0.05.
RESULTS
Modulation of TLR mRNA expression by high glucose: The
results  of  real-time  PCR  indicated  that  high  glucose  can
decrease the mRNA expression of TLR2 and TLR4 in cultured
Figure  1.  Real  time  PCR  shows  the
relative expression of TLR2 and TLR4
mRNA  in  high  glucose  and  high
mannitol treated HCEC compared with
untreated HCEC. The untreated HCEC
is regarded as standard control (RQ=1),
treated  cells  are  expressed  as  the
multiple of the untreated HCEC. Bars
represent means±SEM of 3 independent
experiments. *represent a p<0.05 versus
control. RQ represent relative quantity.
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treated with anti-TLR2 (A) and anti-TLR4 (B) antibodies and stained by Cy3 and DAPI dihydrochloride. There was no immunoreactivity in
the negative control (isotype IgG). Merge means overlap the DAPI and Cy3.
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had no effect on the mRNA expression of TLR2 and TLR4
(Figure 1).
The expression of TLR2 and TLR4 at the protein level: We
next  evaluated  the  protein  of  TLR2  and  TLR4  with
immunofluorescent staining. Staining was not observed in the
cells  that  were  treated  with  normal  mouse  IgG  (control).
Intensity of TLR2 and TLR4 reactivity was slightly inhibited
by  high  glucose,  and  this  inhibition  was  not  observed  in
mannitol treated HCEC (Figure 2A,B).
We also confirmed the protein expression of TLR2 and
TLR4 using western blot with a cellular protein GAPDH as
standard. The results suggest the protein expression of TLR2
Figure 3. Western blot detect the protein expression of TLR2 and
TLR4. A: western blot analyses detect the expression of TLR2 and
TLR4 at the protein level in HCEC under stimulation of high glucose
and  high  mannitol.  Equal  amounts  of  proteins  were  loaded.  B:
Column  diagrams  and  Bars  represent  the  ratio  of  the  scanned
immunoblots of TLR2 and TLR4 to that of GAPDH. Untreated
HCEC  was  regarded  as  control.  Data  are  the  mean±SEM  of
triplicates from an experiment that was repeated three times with
similar results. *represent a p<0.05 versus control.
and TLR4 can be inhibited by high glucose, an inhibition was
also not observed in mannitol treated HCEC (Figure 3A,B).
Pretreatment  with  specific  TLR2  and  TLR4  monoclonal
antibodies counteracted the release of IL-6 and IL-8 inhibited
by  high  glucose:  The  results  of  ELISA  showed  that
pretreatment  of  HCEC  with  anti-TLR2  and/or  anti-TLR4
inhibited the production of IL-6 and IL-8 following exposure
to high glucose. Maximal upregulation was observed in HCF
cells treated with antibodies against both TLR2 and TLR4.
Our results of ELISA also showed that pretreatment of HCEC
with  anti-TLR2  and/or  anti-TLR4  did  not  inhibit  the
production of IL-6 and IL-8 exposure to mannitol (Figure 4).
DISCUSSION
Corneal epithelial cells are constantly exposed to microbial
pathogens and their products on the ocular surface. Although
the  cornea  is  highly  resistant  to  infections  under  normal
conditions, sight-threatening microbial infections may occur
when the corneal integrity is breached by trauma or contact
lens wear. Therefore, the underlying mechanisms that regulate
corneal  epithelial  cell  activation  are  important  in  the
development of infectious keratitis. A previous study had
showed that high glucose delayed epithelial wound closure in
cultured porcine corneas and impaired both basal and wound-
induced  PI  3-kinase/Akt  signaling  pathway  [20].  Delayed
epithelial wound closure may increase risk of the microbial
keratitis. As we know, high glucose has been reported to
increase cornea opportunity infection by fungi, bacteria, and
viruses  in  clinical  observation.  However,  there  is  no
convincing  evidence  that  high  glucose  suppresses  innate
immune responses in the cornea or increase susceptibility to
cornea infections. In this study, we investigated the effects of
high glucose on the innate immune of corneal epithelium. Our
results show that the expression of TLR2 and TLR4 can be
inhibited  by  high  glucose.  The  results  suggest  that  high
glucose  has  the  ability  to  modulate  the  innate  immune
response of cornea epithelium.
In this study, we make the novel observation that high-
glucose  conditions  in  HCEC  inhibit  key  innate  immune
system sensors . Our results show that high glucose dose
induces a marked decrease in TLR2 and TLR4 mRNA and
protein expression, and these effects are not osmotic because
mannitol had no effect. Signaling through TLRs is believed
to  be  the  critical  first  step  in  innate  immune  activation.
Increase  in  TLR2  and  TLR4  expression  observed  here  is
consistent  with  those  reported  in  macrophages  of
atherosclerotic  lesions  [21],  human  endothelial  cells  [22],
smooth muscle cells of coronary arteries [23], dendritic cells
[24], keratinocytes [25], preadipocytes [26], adipocytes [27],
and pancreatic islets [17]. However, all of these studies were
performed  under  nondiabetic  conditions  with  minimal
information on the TLR-mediated downstream signaling and
mechanism of activation. In this context, we have provided
sequential  data  that  in  HCEC,  high  glucose  results  in
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proinflammatory cytokine secretion. Inhibition of TLR2 and
TLR4 together in cells was additive, resulting in a further
decrease in NF-κB activity and indicating that activation of
both receptors is critical.
As  we  know,  recognition  of  pathogen-associated
molecular patterns (PAMP) via TLRs can lead to translocation
of  the  NF-κB,  with  consequent  upregulation  of
proinflammatory  cytokines,  co-stimulatory  molecules,  and
chemokines, such as tumor necrosis factor-α (TNF-α), IL-6,
IL-8,  IL-18,  and  monocyte  chemotactic  protein-1  (MCP)
[28,29]. Our previous study indicated activation of TLRs in
response to P. aeruginosa resulted in the upregulation of IL-8,
the major chemokine that attracts PMNs into the infected
cornea,  and  of  IL-6,  which  activates  polymorphonuclear
neutrophils (PMNs) [30]. A similar study also reported poly
(I: C) and lipopolysaccharide (LPS) induced IL-6 and IL-8
expression  in  human  corneal  epithelial  cells  [31,32].  Our
results show that the expression of TLR2 and TLR4 was
inhibited by high glucose. At the same time, the release of IL-6
and IL-8 also showed similar results. The results suggest that
high glucose may decrease the host inflammatory response
via IL-6 and IL-8. To further prove that the action of high
glucose  may  relate  to  TLRs,  the  cultured  HCEC  was
pretreated  with  specific  TLR2  and  TLR4  monoclonal
antibodies to study the expression of IL-6, 8. Our previous
study showed that pretreatment of HCECs with anti-TLR2 or
anti-TLR4 inhibited the production of IL-6 and IL-8 following
exposure  to  Fusarium  hyphae.  Maximal  inhibition  was
observed in HCEC treated with antibodies against both TLR2
and TLR4 [33]. That is the reason that both TLR2 and TLR4
were blocked in this study. We found that pretreatment of
HCEC  with  anti-TLR2  and  anti-TLR4  upregulated  the
production of IL-6 and IL-8 which inhibited by high glucose.
These results suggest that high glucose may modulate the
immune response through TLR2 and TLR4.
Keratopathy  in  the  presence  of  diabetes  should  be
considered  as  a  potential  sight  threatening  condition  and
thence  must  be  given  appropriate  clinical  attention  and
increased  research  interest.  An  extensive  literature  search
using MEDLINE found no previous descriptions to study the
cornea innate immune of high glucose. Our results suggest
that high glucose may decrease the innate immune through
TLRs in cornea epithelium. This may be one of the reasons
that the risk of cornea infection can be increased in diabetes
patients. However, the fundamental question of how high
glucose inhibits TLR2 and TLR4 in HCEC and how this leads
to decreased inflammation needs further investigation.
One concern has been raised as to why only TLR2 and
TLR4 were chosen to study the action of high glucose. TLR2
and TLR4 were chosen based on the following reasons: 1)
Among the TLR family, TLR2 and TLR4 has been shown to
recognize  a  wide  variety  of  PAMPs,  including  bacterial
lipoproteins, peptidoglycan (PGN) from bacterial cell wall,
and lipoteichoic acids [34-36]. 2) Previous reports on the role
of glucocorticoids in innate immunity always focus on TLR2
and/or TLR4 [37-42]. Our results indicated the action of high
glucose on cornea innate immune may partly be via TLR2 and
TLR4, but whether other TLRs may also play a crucial role
needs further investigation.
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